To make things simple for the registration of cosmetics imported into the country, rule 129, 129H, 135A and 145D of the Drugs and Cosmetics Rules are to be amended by the Union Health Ministry of India. You could have an overview of medical device registration in our blog section under the CDSCO category. The recommendation was given by the highest authority on technical matters under Union Ministry of India, DTAB (The Drugs Technical Advisory Board). The issue was handed to DTAB for examining after the cosmetics importers demand for simplifying the provisions to the health ministry. DTAB’s 68th meeting discussed the issue and formed a sub-committee to address it without any compromise on quality and safety. READ ALSO: Registration of In Vitro Diagnostics in India.
The sub-committee recommended the amendments on the Rules 129, 129H, 135A and 145D after their meeting on 12th June, 2015. The other recommendations are also given to simplify import registration of cosmetics regards to the products not tested on animals, free sale certificate, Letter of Authorization (LoA) consideration in place of Power of Attorney (PoA), Certificate of Free Sale (CFS) requirement and bulk import of cosmetics into the country. After deliberations, DTAB in its 70th meeting held last month agreed to the amendments and guidelines proposed. It also recommended for a test of the cosmetics imported into the country without prior registration and the Central Drugs Standard Control Organization (CDSCO) should maintain the details of the non-registered cosmetics into the country.
Other News
CDSCO Issues Guidelines on Medical Device License Retention
New Delhi, May 15, 2024 — The Central Drugs Standard Control Organization (CDSCO) has released a circular (F. No. MED-15/35/2024-eOffice) on the retention of medical device licenses and certificates under the Medical Devices Rules, 2017. […]
Read More
India Medical Device Pricing Strategy: Ensuring Growth & Affordability
India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]
Read MoreImports of High-Value Medical Equipment
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC Committee: Pioneering Medical Approvals
New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
